A comparative study between efficacy and safety of telmisartan (ARB) and enlapril (ACEI) in hypertensive patients

Abstract

Background Hypertension is the most common cardiovascular disease that affects about 1 billion individuals worldwide1. It is defined conventionally as sustained increase in blood pressure ≥ 140/90mmHg. In India the prevalence of hypertension is 25% in urban population and 10% in rural population The WHO reports that hypertension is responsible for 62% of cerebrovascular disease and 49% ischemic heart disease with little variation by sex. Aims and objectives To compare the efficacy and adverse effect profile of telmisartan and enalapril maleate in essential hypertensive patients. 2. To compare the incidence of adverse effects in both telmisartan and enalapril groups. Methods This was a prospective, observational study conducted on outpatients attending Medicine OPD in SMC/GGH, Vijayawada. A total of 80 patients were recruited in the study and divided in to two groups with 40 patients in each group. The total period of the study was 3 months. Clinical examination findings, investigations and relevant history were obtained from studied patients and entered in the proforma. Periodic recording of blood pressure was done for every 2,6 and 12weeks. Laboratory investigation were carried out before initiation of therapy and at the end of the study. Results Essential hypertension was more in the age group of 50-55 years accounting for n=24 followed by 40-44yrs which was n=20. After 12 weeks of therapy in essential hypertension group systolic blood pressure was reduction to normal level was 85% with telmisartan and 70% with Enalapril maleate. Diastolic B.P. reduction was 70% with telmisartan and 60% with Enalapril maleate treatment in patients after 12 weeks of treatment. Cough – 2.5% telmisartan group, 10% in Enalapril maleate group, between 10-12 weeks. Rash – observed equally 2.5% in telmisartan group. Conclusion In the present study both telmisartan and enalapril maleate reduced both systolic and diastolic blood pressures in both Groups at 2 weeks, 6 weeks and 12 weeks almost equally. But in terms of adverse effect profile, persistent dry cough was observed in 10% of enalapril maleate treated group and 2.5% in telmisartan treated group. Rash was observed 2.5% with both drugs. Telmisartan is effective and better tolerated than enalapril in the treatment hypertension.

Authors and Affiliations

Dr. Ch. Jhansi Vani

Keywords

Related Articles

Hypolipidemic changes in Kanakalinga karpoorati mezhugu therapy in Experimental hypothyroid disorder

Kanaka linga karpoorathi mezhugu is a herbomineral drug preparation used in Siddha system of medicine used to treat thyroid disorders and allied ailments. Known risk factors for thyroid disease include autoimmunity, ext...

AN OVERVIEW ON THE LACK OF PROPER EVALUATION AND STANDARDISED ANALYTICAL METHODS OF CURRENTLY MARKETED HERBAL PRODUCTS: A REMEDIAL APPROACH.

Traditional medicines have been used in chronic and potential life-threatening diseases, and they are widely used by the young, aged people for health maintenance. Herbal therapy is famous as a traditional medical pract...

Study on quality of life in patients with diabetes mellitus

Health-related QOL can be measured with generic measures that are intended to be applicable across different diseases.One of the most widely used generic instruments is the 36-item short form of the Medical Outcomes Stu...

Evaluation of Hepatoprotective and Antioxidant activity of Euphorbia cyanthophora

The present study was carried out to evaluate the hepatoprotective and antioxidant effect of the methonalic extract of Euphorbia cyathophora (MEEC) in Wistar albino rats. Protective action of MEEC was evaluated using a...

In-vitro Antioxidant studies on ethanolic extracts of Boswellia ovalifoliolata and Saccharum spontaneum by DPPH, Nitric oxide and Lipid peroxidation methods.

Oxidative stress is currently suggested a mechanism underlying various degenerative disorders such as atherosclerosis, cancer, aging, diabetes and Alzheimer’s. Chemical principles from nature such as flavonoids and oth...

Download PDF file
  • EP ID EP648130
  • DOI -
  • Views 90
  • Downloads 0

How To Cite

Dr. Ch. Jhansi Vani (2019). A comparative study between efficacy and safety of telmisartan (ARB) and enlapril (ACEI) in hypertensive patients. International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP), 8(2), 142-147. https://www.europub.co.uk/articles/-A-648130